Canut MI, García-Feijoo J, Larrosa-Poves JM, López-López F, Pazos, M,Espinoza-Cámac N, OyagüezI, Del Río T, Rodríguez M
Cost-utility analysis of latanoprost unidose cationic emulsion preservative-free versus latanoprost unidose in the treatment of open-angle glaucoma and ocular hypertension patients in Spain
Expert Rev Pharmacoecon Outcomes Res. 2025;25(9):1337-1343. doi: 10.1080/14737167.2025.2556693
De la Cuadra-Grande A, Rioja-Zuazu J, Domínguez-Esteban M, Torres E, Blissett R, Woodward E, Oyagüez I, Fernández-Arjona M
Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system
Expert Rev Pharmacoecon Outcomes Res. 2023; vol. 23, no. 5, 499–510
Taxonera C, de Andrés-Nogales F, García-López S, Sánchez-Guerrero A, Menchén B, Peral C, Cábez A, Gómez S, López-Ibáñez de Aldecoa A, Casado MA, Menchén L
Cost-Effectiveness Analysis of Using Innovative Therapies for the Management of Moderate-To-Severe Ulcerative Colitis in Spain
Expert Rev Pharmacoecon Outcomes Res. 2021. Doi: .1080/14737167.2021.1880324
Gros B, Soto J, Casado MA
Incorporation of future costs in health economic analysis publications: Current situation and recommendations for the future
Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):465-9
Barbieri M, Drummond M, Puig-Junoy J, Casado MA, Ballina FJ, Blasco P, Poveda JL